Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Quantitative Phosphoproteome Analysis of Rocaglamide A in Triple-negative Breast Cancer cells

ABSTRACT: An TMT-based quantitative phosphoproteome analysis using liquid chromatography–coupled tandem mass spectrometry was performed to acquire proteome-wide expression data on Triple-negative Breast Cancer (TNBC) cells treated with time-course Rocaglamide A.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Hsin-Yi Chang

PROVIDER: PXD048247 | JPOST Repository | Sat Jan 04 00:00:00 GMT 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Phospho%20(STY)Sites.txt	Txt
	TMTPro18x_RocAp_F1.raw	Raw
	TMTPro18x_RocAp_F2.raw	Raw
	TMTPro18x_RocAp_F3.raw	Raw
	TMTPro18x_RocAp_F4.raw	Raw

Items per page:

1 - 5 of 8

Similar Datasets

Quantitative Proteome Analysis of Rocaglamide A in Triple-negative Breast Cancer cells

Project description:An iTRQA-based quantitative proteome analysis using liquid chromatography–coupled tandem mass spectrometry was performed to acquire proteome-wide expression data on Triple-negative Breast Cancer (TNBC) cells treated with Rocaglamide A for 24 hours.

2024-12-08 | PXD047648 | JPOST Repository

TP53 signature predicts survival outcome in triple-negative breast cancer with neoadjuvant chemotherapy

Project description:In the study presented here, a consecutively operated, well-defined cohort of 30 triple-negative breast cancer cases with neoadjuvant chemotherapy, followed up more than five years, was used to acquire TP53 signature composed of a total of 33 genes. Combining the response to NAC and the TP53signature score in triple-negative breast cancer was able to predict an unfavorable prognosis.

2021-12-10 | GSE190275 | GEO

E-GEOD-27447

Project description:FZD7 Plays a Critical Role in Triple Negative Breast Cancer Proliferation

2025-01-24 | E-GEOD-27447 | ExpressionAtlas

E-GEOD-38959

Project description:Gene expression profiling of triple negative breast cancer, normal ductal cells, and normal tissues

2025-01-24 | E-GEOD-38959 | ExpressionAtlas

DNA methylation profiling of 154 triple negative breast cancers using the Illumina EPIC 850K platform

Project description:Genome-wide DNA methylation profiles for 154 triple negative breast cancer (TNBC) samples from the Swedsh Cancerome Analysis Network - Breast (SCAN-B) cohort.

2025-02-24 | GSE148906 | GEO

Metastasis in triple-negative breast cancer

Project description:Metastasis in triple-negative breast cancer

| PRJNA437929 | ENA

FOXC1 in triple negative breast cancer

Project description:FOXC1 in triple negative breast cancer

| PRJNA882754 | ENA

DNA methylation profiling of 82 triple negative breast cancers with BRCA1 promoter methylation or BRCA1 mutation using the Illumina EPIC 850K platform.

Project description:Genome-wide DNA methylation profiles for 82 triple negative breast cancer (TNBC) samples from the Swedsh Cancerome Analysis Network - Breast (SCAN-B) cohort.

2020-06-11 | GSE148748 | GEO

SIPA1 expression in breast cancer patient

Project description:To study the expression of SIPA1 in patients with metastatic triple-negative breast cancer, we obtained a subcutaneous metastatic sample from a patient with stage III triple-negative breast cancer and performed single-cell transcriptome sequencing

2022-12-31 | GSE221731 | GEO

E-MTAB-5243

Project description:Ampliseq transcriptomic array of REF seq. genes in ZEB1 knock out triple negative breast cancer cells

2025-01-23 | E-MTAB-5243 | ExpressionAtlas